Betamethasone/calcipotriene Side Effects

Please note - some side effects for Betamethasone/calcipotriene may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.

Side Effects of Betamethasone/calcipotriene - for the Consumer

Betamethasone/calcipotriene Ointment

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Betamethasone/calcipotriene Ointment:

Dry skin; headache; itching; mild burning at the application site; throat irritation.

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); acne-like rash; burning, cracking, irritation, redness, or peeling skin not present before you began using betamethasone/calcipotriene ointment; excessive hair growth; inflamed hair follicles; inflammation around the mouth; muscle weakness; thinning, softening, or discoloration of the skin; unusual weight gain, especially in the face.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

Side Effects by Body System - for Healthcare Professionals

Applies to: topical ointment; topical suspension

Dermatologic

Dermatologic side effects reported in clinical trials have included pruritus (3.1%), psoriasis (1.2%), scaly rash (1.2%), erythema (0.6%), skin irritation (0.4%), pain (0.3%), and burning sensation (0.2%). Other, less common reactions (less than 1%) include folliculitis, rash papular, rash pustular, and skin hypopigmentation. Skin atrophy, telangiectasia, and skin hyperpigmentation were reported infrequently.

Respiratory

Respiratory side effects reported in clinical trials have included nasopharyngitis (2.3%), influenza (0.9%), and upper respiratory tract infection (0.8%).

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.